F Flais
Overview
Explore the profile of F Flais including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mure-Zamparini M, Fiant A, Filipov T, Flais F, Fobe F, Hanouz J
Ann Fr Anesth Reanim
. 2014 Oct;
33(9-10):550-1.
PMID: 25282443
No abstract available.
2.
Letouze N, Jokic M, Maragnes P, Rouleau V, Flais F, Vabret A, et al.
Arch Mal Coeur Vaiss
. 2006 Jun;
99(5):514-6.
PMID: 16802745
Fulminant Influenza type A-associated myocarditis are very rare in children. The clinical presentation is non specific, like flu illness, cardiogenic shock or sudden cardiac arrest. We report the case of...
3.
du Cheyron D, Lesage A, Le Page O, Flais F, Leclercq R, Charbonneau P
J Clin Pathol
. 2003 Nov;
56(11):879-81.
PMID: 14600140
This report describes two cases of Osler's triad of pneumonia, meningitis, and endocarditis, as a result of Streptococcus pneumoniae infection, also called Austrian's syndrome. In the first patient, a 51...
4.
Picard S, Rouet R, Ducouret P, Puddu P, Flais F, Criniti A, et al.
Br J Pharmacol
. 1999 Aug;
127(7):1687-95.
PMID: 10455327
1. In order to investigate the role of KATP channel activation and repolarization dispersion on the 'border zone' arrhythmias induced by ischaemia-reperfusion, the effects of glibenclamide and bimakalim, agents modifying...
5.
Picard S, Rouet R, Flais F, Ducouret P, Babatasi G, Khayat A, et al.
Anesthesiology
. 1998 May;
88(5):1318-29.
PMID: 9605693
Background: Bupivacaine may have toxic cardiovascular effects when accidentally administered by intravascular injection. However, its electrophysiologic effects in the presence of myocardial ischemia remain unknown. The authors evaluated the electrophysiologic...
6.
Picard S, Rouet R, Monti F, Puddu P, Ducouret P, Flais F, et al.
J Cardiovasc Pharmacol
. 1998 Feb;
31(1):126-39.
PMID: 9456287
Considering the Survival With ORal D-sotalol (SWORD) study results, in which mortality was higher in patients treated by the pure class III agent D-sotalol, we tested DL- and D-sotalol (5...